๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic gene silencing in neurological disorders, using interfering RNA

โœ Scribed by G. Scott Ralph; Nicholas D. Mazarakis; Mimoun Azzouz


Publisher
Springer
Year
2005
Tongue
English
Weight
180 KB
Volume
83
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sequence-specific gene silencing in muri
โœ Tsunao Kishida; Hidetsugu Asada; Satoshi Gojo; Suzuyo Ohashi; Masaharu Shin-Ya; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 156 KB

## Abstract ## Background Postโ€genomic biomedical research requires efficient techniques for functional analyses of poorly characterized genes in living organisms. Sequenceโ€specific gene silencing in mammalian organs may provide valuable information on the physiological and pathological roles of p

Quantitative and temporal analysis of ge
โœ Yuki Takahashi; Kiyoshi Yamaoka; Makiya Nishikawa; Yoshinobu Takakura ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB

Vector-based RNA interference (RNAi) has attracted great interest, because of its more prolonged gene silencing effect compared with small interfering RNA (siRNA). However, the intensity and duration of vector-based RNAi effect has received little attention. In this study, the gene silencing kinetic

Prolonged gene silencing in hepatoma cel
โœ Roosmarijn E. Vandenbroucke; Bruno G. De Geest; Stefan Bonnรฉ; Mathieu Vinken; Ta ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 638 KB

## Abstract ## Background Small interfering (si)RNA mediated inhibition of oncogenes or viral genes may offer great opportunities for the treatment of several diseases such as hepatocellular carcinoma and viral hepatitis. However, the development of siRNAs as therapeutic agents strongly depends on

Local matrix metalloproteinase 2 gene kn
โœ Hanna Hlawaty; Aurรฉlie San Juan; Marie-Paule Jacob; Roger Vranckx; Didier Letour ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 352 KB

## Abstract ## Background Small interfering RNA (siRNA) delivery is a promising approach for the treatment of cardiovascular diseases. Matrix metalloproteinase (MMP) 2 overโ€expression in the arterial wall has been implicated in restenosis after percutaneous coronary intervention, as well as in spo